Procter & Gamble Files Preliminary Prospectus Supplement for Multi-Tranche Euro Notes Offering
PROCTER & GAMBLE Co
Subscribe to track PG
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Procter & Gamble Co ($PG) has filed a Form 424B5 preliminary prospectus supplement for a multi-tranche offering of Euro-denominated senior notes. Joint book-running managers include Citigroup, Deutsche Bank, Goldman Sachs & Co. LLC, HSBC, and Morgan Stanley. The notes will be listed on the NYSE.
Comprehensive Analysis
Executive Summary
The Procter & Gamble Company (NYSE: PG) filed a preliminary prospectus supplement under Rule 424(b)(5) on October 27, 2026, relating to a proposed offering of multi-tranche Euro-denominated senior notes under its shelf registration statement (Registration No. 333-299472).
Key Offering Details
- Issuer: The Procter & Gamble Company
- Security: Multi-tranche Euro-denominated Notes (Senior unsecured obligations)
- Denominations: €100,000 and integral multiples of €1,000 in excess thereof
- Listing: Application will be made to list the notes on the New York Stock Exchange (NYSE)
- Clearing Systems: Clearstream Banking, S.A. and Euroclear Bank SA/NV
- Joint Book-Running Managers: Citigroup, Deutsche Bank, Goldman Sachs & Co. LLC, HSBC, and Morgan Stanley
- Pricing & Coupon: Subject to completion (pricing terms bracketed in preliminary supplement)
Market Impact & Significance
This filing represents standard corporate debt financing to optimize the company's capital structure and fund operational needs or debt refinancing. Because this is a preliminary debt prospectus supplement rather than insider transaction activity or an equity dilution event, the direct trading impact on common shares is expected to be low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
